If you have any question, please feel free to email us. We will touch with you as soon as possible.
Erbitux is indicated alone or in combination with irinotecan for the treatment of metastatic rectal cancer with epidermal growth factor (EGF) receptor overexpression that is resistant to irinotecan based chemotherapy regimens. For R&D purposes only.
* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.
| Generic name | Cetuximab Solution for Infusion |
| Trade name | Erbitux |
| Specification | 100mg/20ml |
| Main ingredients | CETUXIMAB |
| Appearance | This product is a solution for injection. It is colourless and may contain white visible amorphous particles associated with the product. |
| Manufacturer | Merck Healthcare KGaA |
| MA Holder | Merck Europe B.V. |
Indications
This product is indicated alone or in combination with irinotecan for the treatment of metastatic rectal cancer with epidermal growth factor (EGF) receptor overexpression that is resistant to irinotecan based chemotherapy regimens.
For more details,pls contact Janney:
Email: tosun-global@upharm.cn
Wechat/Whatsapp:(+86)18922120575
Hot Tags: Erbitux Cetuximab Solution For Infusion Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Adefovir Dipivoxil Tablets, Bimatoprost Ophthalmic, Agomelatine Tablets, Phenytoin Sodium Tablets, Acarbose Tablets, AdapaleneGel
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China
